Pregnancy loss can be caused by several factors involved in human reproduction. Although up to 50% of cases remain unexplained, it has been postulated that the major cause of failed pregnancy is an error of embryo implantation. Transmembrane mucin-1 (MUC-1) is a glycoprotein expressed on the endometrial cell surface which acts as a barrier to implantation. The gene that codes for this molecule is composed of a polymorphic tandem repeat of 60 nucleotides. Our objective was to determine if MUC-1 genetic polymorphism is associated with implantation failure in patients with a history of recurrent abortion. The study was conducted on 10 women aged 25 to 35 years with no history of successful pregnancy and with a diagnosis of infertility. The control group consisted of 32 patients aged 25 to 35 years who had delivered at least two full-term live children and who had no history of abortions or fetal losses. MUC-1 amplicons were obtained by PCR and observed on agarose and polyacrylamide gel after electrophoresis. Statistical analysis showed no significant difference in the number of MUC-1 variable number of tandem repeats between these groups (P > 0.05). Our results suggest that there is no effect of the polymorphic MUC-1 sequence on the implantation failure. However, the data do not exclude MUC-1 relevance during embryo implantation. The process is related to several associated factors such as the mechanisms of gene expression in the uterus, specific MUC-1 post-translational modifications and appropriate interactions with other molecules during embryo implantation.
Pregnancy loss has been attributed to several factors involved in human reproduction: genetic and uterine abnormalities, endocrine and immunological dysfunctions, infectious agents, environmental pollutants, psychogenetic factors, and endometriosis (1) . Although several medical causes have been established, up to 50% of cases of recurrent pregnancy loss, defined as two or more spontaneous abortions, still remain unexplained after standard gynecological, hormonal, and karyotype investigations (2) . However, it has been postulated that the major single cause of failed pregnancy is an error of embryo implantation, which may be as high as 78% in humans (1) .
Embryo implantation is a complex and progressive process which involves synchronous molecular events in the uterus and the embryo promoting a perfect interaction between them. This phenomenon is characterized by apposition, adhesion and invasion of the endometrium by the blastocyst.
The establishment of consistent junctions between the embryo trophoblast and the endometrium requires the expression of adhesion molecules and elimination of nonadhesive molecules from the apical cell lining of both tissues. In this phase, called pre-implantation period, the embryo plays an important role in the receptive phase of implantation, modulating endometrial molecules and controlling the implantation process (3) .
Although the details of implantation vary among different species, the basic features of blastocyst attachment to and penetration of the uterine surface epithelium are common to many mammals (4) . Based on these data, many experimental animal models have been elaborated to elucidate the main molecular events which occur at the beginning of implantation. One of the molecules that have been extensively studied is mucin-1 (MUC-1), also known as episialin (5) .
MUC-1 is a glycoprotein expressed on the epithelial surface of different types of tissues, including the endometrium (6, 7) . This mucin has a polymorphic extracellular protein core containing a large domain of variable number of 20 highly conserved amino acids in tandem repeats, which in humans range from 30 to 90 repeats (8, 9) .
The presence of MUC-1 on the endometrial cell surface plays an important role in reproductive genetics because the molecule can act as a barrier, maintaining the uterus non-receptive to the embryo (10) .
In 1998, DeLoia et al. (11) observed a great reduction in the expression of MUC-1 in uterine surface epithelium during the receptive phase in mice. The same observations were made in sheep, pigs and baboons, showing that MUC-1 expression is downregulated during the implantation window (12) (13) (14) .
In humans, although progesterone upregulates MUC-1 expression in the receptive state of the uterus, it is controversial if this molecule has a true anti-adhesion function on the apical epithelial surface of the endometrium or if MUC-1 acts as the first site of embryo attachment (3). However, we cannot exclude the possibility that the embryo has a local effect on the implantation site, cleaving or locally down-regulating MUC-1, as observed in rabbits (15) .
Horne et al. (7) compared fertile and infertile women in an attempt to associate the failure of embryo implantation with MUC-1 allele size, analyzing the polymorphic variable number of tandem repeats (VNTRs) of the MUC-1 gene region. The results indicated a higher frequency of smaller alleles in women with infertility due to embryo implantation failure when compared to patients with no history of infertility.
In contrast, Goulart et al. (16) , comparing the MUC-1 genotype of 10 fertile and 10 infertile women, proposed that there was no association between VNTRs and embryo implantation in women with history of implantation failure or in women with reproductive success.
The aim of the present study was to determine if MUC-1 polymorphism is related to implantation failure in women with a history of recurrent abortion and with a diagnosis of infertility.
The infertile group consisted of 10 patients aged from 25 to 35 years, with no history of successful pregnancy, presenting two or more pregnancy losses and a diagnosis of infertility. The patients were evaluated on the basis of routine parameters including a complete hormonal profile (prolactin, free thyroxine, follicle-stimulating hormone, luteinizing hormone, and testosterone) and full-cycle evaluation. Tubal patency was confirmed by hysterosalpingography. The results of all tests were within the normal range, and the patients were defined as having unexplained infertility. All of them presented normal karyotypes with 46,XX chromosomes after conventional cytogenetic analysis.
The control group consisted of 31 patients referred to the Contraception Outpatient Clinic of the University Hospital, School of Medicine of Ribeirão Preto, University of São Paulo, SP, Brazil. The inclusion criteria for the fertile group were age from 25 to 35 years, at least two term pregnancies, 2 live children, and no history of abortions or fetal losses.
Approximately 2.0 mL of peripheral blood was collected from each patient into sterile Vacutainer  tubes containing EDTA. Genomic DNA was extracted by adding 1.0 mL of lysis buffer (12 mmol/L Tris-HCl, pH 7.5, 5 mmol/L EDTA, pH 7.5, 320 mmol/L sucrose, 5 mmol/L MgCl 2 , 4% Triton X-100) to 500 µL of whole blood. The DNA was dried at room temperature and dissolved in 60 µL of sterile ultrapure water.
The desired PCR products flank the VNTR region of the MUC-1 gene (GenBank accession No. M61170). They were obtained using the primer pair AGCCACAGCCCCG GTTCAGG (sense, nucleotide position 3627-3646) and GTGCACCAGAGTAGAAGC TGAGCC (antisense, nucleotide position 3999-4022). The amplification conditions were: 20 pmol of primers, 0.75 mmol/L MgSO 4 , 300 µmol/L dNTP, 0.5 U Pfx DNA polymerase, 1X Pfx buffer, 1X enhancer solution (Invitrogen, Carlsbad, CA, USA), and 50 ng/µL DNA template. Thirty-four cycles were performed according to the following conditions: 35 s at 94ºC, 1 min at 60ºC, and 2 min and 30 s at 68ºC. We also preheated a DNA solution at 94ºC for 3 min and, after complete PCR cycling, we performed a final extension of 10 min at 68ºC.
The amplicons were observed after 1.2% agarose gel electrophoresis. The gel was stained with ethidium bromide (5 µL/100 mL gel) at 95 V for 2 h and 30 min and the products were visualized under UV light and photographed with a DC120 Kodak Digital Science camera (Rochester, NY, USA). The base pair size of each amplicon was estimated on the basis of a DNA size ladder (1 kb Plus Ladder, Invitrogen). We confirmed the results using 8.0% polyacrylamide gel. The number of MUC-1 VNTR was calculated using the following formula: N -275 bp/60, where N is the amplicon size (in base pairs), 275 bp is the outside region of the MUC-1 VNTR and 60 is the number of nucleotides within the core repeats that comprise the MUC-1 VNTR (Figure 1 ).
Thirteen control patients were genotyped as homozygotes and 18 as heterozygotes, and 3 homozygotes and 7 heterozygotes were observed in the infertile group. We detected a prevalence of heterozygotes in both groups. Three different alleles with 20, 22, and 34 repeats were observed only in the infertile group, although this group was not as large as the control group. The average sizes of the upper and lower alleles and the allelic range as well as the allelic frequencies of the patients of both groups are shown in Table 1 .
The mean values of samples with unequal variances were compared by the Student t-test (PROC TTEST, Satterthwaite method, Statistical Analysis System, 2004) (17) and no significant difference in the www.bjournal.com.br number of VNTR motifs was detected between the two groups (P > 0.05). We also excluded the hypothesis that homozygous or heterozygous MUC-1 VNTR genotype could be related to the fertile or infertile phenotype (OR = 0.7013, CI = 0.1494-3.2930). Pregnancy loss is one of the leading problems of female health considering that 9 to 13% of women of reproductive age experience one clinically recognized loss, 5% experience two or more losses, and 1 to 2% suffer three or more losses (2), with embryo implantation failure being considered the main problem.
MUC-1 is a high-molecular weight cell surface O-glycosylated-associated glycoprotein expressed in several mammalian cells. In the uterus, the expression of this mucin is thought to be an important factor in determining endometrial receptivity since it is upregulated during the implantation window (18) . Modifications in the internal structure of MUC-1 VNTR could generate changes in the number of core protein O-glycosylation sites, altering molecule immunogenicity (19) and possibly leading to pregnancy loss. Although this is reasonable, the present study indicates that the number of VNTR of MUC-1 is not associated with implantation failure in women with recurrent abortion.
Horne et al. (7) and Goulart et al. (16) have tried to associate MUC-1 VNTR polymorphism with female infertility, with discordant results. We could not find additional data about this hypothesis in the literature. The first study found a median size of 3.4 kb (55 repeats) for the lower allele in the fertile group and 2.5 kb (40 repeats) in the infertile group, suggesting a higher frequency of smaller MUC-1 alleles in women with implantation failure. The second study reported an average size for the lower allele of 1.69 kb (24 repeats) in both groups. The upper allele presented an average size of 2.49 kb in the infertile group and 2.35 kb in the control group. Thus, Goulart and colleagues demonstrated that MUC-1 VNTR polymorphism was not significantly different between the two groups analyzed.
The wide variation among MUC-1 genotypes in our samples could be related to the multiethnic composition of both groups, in contrast to the study of Horne et al. (7) who investigated a homogeneous sample of 20 European women's genotypes. These investigators considered as fertile, women who delivered at least two full-term children after spontaneous and uneventful pregnancies, but they did not mention if these women had presented any abortions or other gestational history.
In the present study, there was no evidence of an association between the polymorphic VNTR MUC-1 sequence and implantation failure. However, these data are based on a small number of selected patients and reflect one of the maternal factors involved in the complex phenomenon of embryo implantation.
